sapylin
Small moleculeexperimental
Clinical trial activity
6 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
2
Earliest trial started Apr 1, 2000 (NCT00010452)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ok432
- ok432
- ok-432
- ok-432
- picibanil
- picibanil
- sapylin
- sapylin
- sapylin
- streptococcal preparation 722
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02502643 | N/A | Jul 1, 2015 | National Taiwan University |
| NCT02158299 | Phase 4 | Oct 1, 2013 | Guangzhou Medical University, Sun Yat-Sen University |
| NCT01699347 | Phase 4 | Sep 1, 2012 | University of Haifa |
| NCT01149902 | Phase 1 | Jul 1, 2010 | University of Yamanashi |
| NCT00795977 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2003 | Fukushima Medical University |
| NCT00010452 | Phase 2/Phase 3 (Phase 3) | Apr 1, 2000 | University of Iowa |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fukushima Medical University | Academic/Hospital | 1 | 1 | 1 | 2003 |
| Guangzhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| National Taiwan University | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| University of Haifa | Academic/Hospital | 1 | 1 | 1 | 2012 |
| University of Iowa | Academic/Hospital | 1 | 1 | 1 | 2000 |
| University of Yamanashi | Academic/Hospital | 1 | 1 | 1 | 2010 |
7 organizations
Page 1 / 1